土三七致肝小静脉闭塞病治疗的单中心回顾性研究

被引:41
作者
王轶
诸葛宇征
张峰
张明
张玮
贺奇彬
邹晓平
机构
[1] 南京大学医学院附属鼓楼医院消化科
关键词
土三七; 肝静脉闭塞性疾病; 肝素, 低相对分子质量; 华法林; 门体分流术, 经颈静脉肝内;
D O I
暂无
中图分类号
R575 [肝及胆疾病];
学科分类号
100201 [内科学];
摘要
目的探讨采用不同治疗方法对由食用土三七所致的肝小静脉闭塞病(HVOD)患者预后的影响。方法纳入2008年7月至2016年1月因食用土三七而导致HVOD的85例患者, 均给予基础保肝和改善微循环等对症治疗, 再根据不同治疗方案分成非抗凝治疗组、非抗凝治疗转经颈静脉肝内门体静脉分流术(TIPS)组、抗凝治疗组、抗凝治疗转TIPS组和抗凝-TIPS阶梯治疗组, 观察各组的临床疗效。统计学分析采用卡方检验。结果 22例未采用抗凝治疗的患者中, 6例(27.3%)临床治愈, 14例(63.6%)在治疗期间死亡, 2例(9.1%)因治疗无效而接受TIPS治疗并长期存活。63例采用低分子肝素联合华法林抗凝治疗的患者中, 6例(9.5%)死亡, 36例(57.1%)临床治愈, 治愈率高于非抗凝治疗组(χ2=5.820, P=0.016);另有21例患者接受TIPS治疗, 其中1例因手术失败而死于手术并发症, 其余患者均长期存活。抗凝-TIPS阶梯治疗组的临床治愈率为88.9%(56/63), 高于非抗凝治疗组, 差异有统计学意义(χ2=31.350, P<0.01)。结论与常规的保肝和对症治疗相比, 抗凝治疗显著提高了土三七所致HVOD患者的临床治愈率。抗凝-TIPS阶梯治疗则进一步提高了其治愈率。
引用
收藏
相关论文
共 11 条
[1]
土三七致肝小静脉闭塞病的临床特点分析 [J].
顾超 ;
邹晓平 ;
徐肇敏 ;
诸葛宇征 .
中华消化杂志, 2010, (10)
[2]
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT) [J].
Mohty, M. ;
Malard, F. ;
Abecassis, M. ;
Aerts, E. ;
Alaskar, A. S. ;
Aljurf, M. ;
Arat, M. ;
Bader, P. ;
Baron, F. ;
Bazarbachi, A. ;
Blaise, D. ;
Ciceri, F. ;
Corbacioglu, S. ;
Dalle, J-H ;
Duarte, R. F. ;
Fukuda, T. ;
Huynh, A. ;
Masszi, T. ;
Michallet, M. ;
Nagler, A. ;
NiChonghaile, M. ;
Pagluica, T. ;
Peters, C. ;
Petersen, F. B. ;
Richardson, P. G. ;
Ruutu, T. ;
Savani, B. N. ;
Wallhult, E. ;
Yakoub-Agha, I. ;
Carreras, E. .
BONE MARROW TRANSPLANTATION, 2015, 50 (06) :781-789
[3]
In Silico Prediction of the Site of Oxidation by Cytochrome P450 3A4 That Leads to the Formation of the Toxic Metabolites of Pyrrolizidine Alkaloids [J].
Fashe, Muluneh M. ;
Juvonen, Risto O. ;
Petsalo, Aleksanteri ;
Vepsalainen, Jouko ;
Pasanen, Markku ;
Rahnasto-Rilla, Minna .
CHEMICAL RESEARCH IN TOXICOLOGY, 2015, 28 (04) :702-710
[4]
Sinusoidal Obstruction Syndrome (Hepatic Veno-Occlusive Disease) [J].
Fan, Cathy Q. ;
Crawford, James M. .
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2014, 4 (04) :332-346
[5]
A Murine Model of Hepatic Veno-occlusive Disease Induced by Allogeneic Hematopoietic Stem Cell Transplantation [J].
Zeng, Lingyu ;
An, Licai ;
Fang, Ting ;
Pan, Bin ;
Sun, Haiying ;
Chen, Chong ;
Cao, Jiang ;
Li, Zhenyu ;
Xu, Kailin .
CELL BIOCHEMISTRY AND BIOPHYSICS, 2013, 67 (03) :939-948
[6]
BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation [J].
Dignan, Fiona L. ;
Wynn, Robert F. ;
Hadzic, Nedim ;
Karani, John ;
Quaglia, Alberto ;
Pagliuca, Antonio ;
Veys, Paul ;
Potter, Michael N. .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (04) :444-457
[7]
Defibrotide: Properties and clinical use of an old/new drug [J].
Pescador, R. ;
Capuzzi, L. ;
Mantovani, M. ;
Fulgenzi, A. ;
Ferrero, M. E. .
VASCULAR PHARMACOLOGY, 2013, 59 (1-2) :1-10
[8]
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial [J].
Corbacioglu, Selim ;
Cesaro, Simone ;
Faraci, Maura ;
Valteau-Couanet, Dominique ;
Gruhn, Bernd ;
Rovelli, Attilio ;
Boelens, Jaap J. ;
Hewitt, Annette ;
Schrum, Johanna ;
Schulz, Ansgar S. ;
Mueller, Ingo ;
Stein, Jerry ;
Wynn, Robert ;
Greil, Johann ;
Sykora, Karl-Walter ;
Matthes-Martin, Susanne ;
Fuehrer, Monika ;
O'Meara, Anne ;
Toporski, Jacek ;
Sedlacek, Petr ;
Schlegel, Paul G. ;
Ehlert, Karoline ;
Fasth, Anders ;
Winiarski, Jacek ;
Arvidson, Johan ;
Mauz-Koerholz, Christine ;
Ozsahin, Hulya ;
Schrauder, Andre ;
Bader, Peter ;
Massaro, Joseph ;
D'Agostino, Ralph ;
Hoyle, Margaret ;
Iacobelli, Massimo ;
Debatin, Klaus-Michael ;
Peters, Christina ;
Dini, Giorgio .
LANCET, 2012, 379 (9823) :1301-1309
[9]
VENO-OCCLUSIVE DISEASE OF THE LIVER ESSENTIAL PATHOLOGY.[J].Bras G.;Hill K.R..The Lancet.1956, 6935
[10]
Serous Hepatosis: A Pathogenesis of Hepatic Fibrosis in Jamaican Children.[J].HILL K R;RHODES K;STAFFORD J L;AUB R.British Medical Journal.1953, 4802